Author

Mark J. C. Nuijten

Observed names: Dr. Mark Nuijten, M Nuijten, M. J. C. Nuijten, M. Nuijten, M.J.C. Nuijten, Mark J C Nuijten, Mark J.C. Nuijten, Mark JC Nuijten, Mark Nuijten
ORCID: 0000-0003-3523-0351
Observed ORCID: 0000-0003-3523-0351
OpenAlex ID: A5103101662
2013 · Karen Freijer, Martijn J.L. Bours, et al. · Journal of the American Medical Directors Association · 82
1998 · Mark J.C. Nuijten · PharmacoEconomics · 65
2010 · M. J. C. Nuijten, T. Mittendorf, et al. · The European Journal of Health Economics · 51
2011 · Mark J. C. Nuijten, Dominique J. Dubois · Frontiers in Pharmacology · 46
2022 · Xavier G.L.V. Pouwels, Christopher J. Sampson, et al. · Value in Health · 30
2012 · Hans-Joerg Fugel, Mark Nuijten, et al. · Frontiers in Pharmacology · 29
2016 · Bjoern Schwander, Mickaël Hiligsmann, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 26
2000 · Peter A.G.M. De Smet, Gouke Bonsel, et al. · PharmacoEconomics · 21
2016 · Hans-Joerg Fugel, Mark Nuijten, et al. · Frontiers in Pharmacology · 16
2001 · M.J.C. Nuijten, P. Berto, et al. · The European Journal of Health Economics · 16
2020 · Mark Nuijten, Stefano Capri · Journal of Market Access & Health Policy · 14
2021 · Mark Nuijten, Philippe Van Wilder · BMC Health Services Research · 13
2017 · Mark Nuijten · Journal of Rare Diseases Research & Treatment · 13
2020 · Bjoern Schwander, Mark Nuijten, et al. · Health Policy and Technology · 12
1999 · Mark JC Nuijten · Value in Health · 12
2005 · Mark Nuijten · PharmacoEconomics · 10
2018 · Mark J. C. Nuijten, Jan Vis · Nature Reviews Clinical Oncology · 9
Works count: 64
Citation count: 1,567
H-index: 14
I10-index: 24
Year
Topic
Type